Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data.
暂无分享,去创建一个
[1] D. Brennan,et al. Mapping oral health related quality of life to generic health state values , 2006, BMC Health Services Research.
[2] K. Zimmermann,et al. PSEUDO‐R2 MEASURES FOR SOME COMMON LIMITED DEPENDENT VARIABLE MODELS , 1996 .
[3] Andrew Bottomley,et al. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[5] Jacek A Kopec,et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. , 2005, Social science & medicine.
[6] Ross D Crosby,et al. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[7] J. Brazier,et al. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices , 2002 .
[8] R. Brooks. EuroQol: the current state of play. , 1996, Health policy.
[9] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[10] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[11] J. Bond,et al. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. , 2005, Health technology assessment.
[12] Andrew Booth,et al. A Review of the Use of Health Status Measures in Economic Evaluation , 1999, Journal of health services research & policy.
[13] R. Prescott,et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. , 2007, Health technology assessment.
[14] R. Deyo,et al. Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life , 1989, Medical care.